<DOC>
	<DOCNO>NCT02875899</DOCNO>
	<brief_summary>Prospective , single-arm , multicentre , international Registry Surfacer System treatment patient limit diminish upper body venous access pathology impede standard access methods.The purpose post-market Registry ass standard care clinical outcome Surfacer System use clinical routine accord approved commercial indication .</brief_summary>
	<brief_title>Surfacer System Facilitate Access Venous Occlusions</brief_title>
	<detailed_description>This prospective , single-arm , multicenter registry Surfacer System patient limit diminish upper body venous access pathology impede standard access method . The need long term access lack availability vein lead development Surfacer System , facilitate reliable repeatable placement central venous catheter restore central venous access . Based European legislation , Registry consider observational study . No additional diagnostic monitoring procedure result inclusion apply patient . Available data collect protected database . Up 30 patient enrol 5 site Europe . Patients require central venous access enrol meet inclusion exclusion criterion device indicate .</detailed_description>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<criteria>patient refer placement central venous catheter patient limit diminish upper body venous access pathology impede standard access method sign informed consent vulnerable subject incapable give consent contraindication central venous access base treat physician opinion standard care occlusion right femoral vein occlusion iliac vein occlusion inferior vena acute thrombosis within vessel ( IVC , brachiocephalic subclavian )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>